EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, NeuroOne Medical Technologies's Enterprise Value is $27.77 Mil.
NeuroOne Medical Technologies's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-13.56 Mil. Therefore, NeuroOne Medical Technologies's EV-to-EBIT for today is -2.05.
The historical rank and industry rank for NeuroOne Medical Technologies's EV-to-EBIT or its related term are showing as below:
NMTC'
s EV-to-EBIT Range Over the Past 10 Years
Min: -12.61 Med: -1.9 Max: 0.35
Current: -2.05
During the past 13 years, the highest EV-to-EBIT of NeuroOne Medical Technologies was 0.35. The lowest was -12.61. And the median was -1.90.
NMTC's EV-to-EBIT is ranked worse than 100% of 465
companies
in the Medical Devices & Instruments industry
Industry Median: 19.21
vs NMTC: -2.05
Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. NeuroOne Medical Technologies's Enterprise Value for the quarter that ended in Dec. 2023 was $36.71 Mil.
NeuroOne Medical Technologies's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-13.56 Mil. NeuroOne Medical Technologies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -36.94%.
NeuroOne Medical Technologies EV-to-EBIT Historical Data
The historical data trend for NeuroOne Medical Technologies's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
NeuroOne Medical Technologies Annual Data
Trend
Dec14
Dec15
Dec16
Dec17
Sep18
Sep19
Sep20
Sep21
Sep22
Sep23
EV-to-EBIT
-1.25
-1.11
-4.11
-1.64
-1.35
NeuroOne Medical Technologies Quarterly Data
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Sep23
Dec23
EV-to-EBIT
-1.35
-2.42
-1.82
-1.35
-2.71
Competitive Comparison
For the Medical Devices subindustry, NeuroOne Medical Technologies's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NeuroOne Medical Technologies EV-to-EBIT Distribution
For the Medical Devices & Instruments industry and Healthcare sector, NeuroOne Medical Technologies's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where NeuroOne Medical Technologies's EV-to-EBIT falls into.
NeuroOne Medical Technologies EV-to-EBIT Calculation
NeuroOne Medical Technologies's EV-to-EBIT for today is calculated as:
NeuroOne Medical Technologies's current Enterprise Value is $27.77 Mil.
NeuroOne Medical Technologies's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-13.56 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NeuroOne Medical Technologies (NAS:NMTC) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
NeuroOne Medical Technologies's Enterprise Value for the quarter that ended in Dec. 2023 was $36.71 Mil.
NeuroOne Medical Technologies's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-13.56 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NeuroOne Medical Technologies EV-to-EBIT Related Terms
Thank you for viewing the detailed overview of NeuroOne Medical Technologies's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
NeuroOne Medical Technologies (NeuroOne Medical Technologies) Business Description
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NMTC has been successfully added to your 